James Salem is an Endocrinology/Metabolic physician affiliated with Summa Health System. OpenAlex indexes 19 publications with 422 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Arch St
Suite 301
Akron, OH 443041429
Telephone
330-434-9121Registry record last updated 21 Sept 2011.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20252 payments
- Medtronic, Inc.Program year20251 payment
- Amgen Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
57.3%Insulin Analog23.7%Lantus Solostar25%Novolog Flexpen10%Humalog Kwikpen U-10010%Basaglar Kwikpen U-1007%Humalog7%Insulin Aspart Flexpen6%Insulin Lispro Kwikpen U-1005%Toujeo Solostar5%Lantus3%Toujeo Max Solostar3%Novolog3%Levemir Flexpen3%Tresiba Flextouch U-2002%Fiasp Flextouch2%Semglee (Yfgn) Pen2%Tresiba Flextouch U-1002%Insulin Lispro2%Admelog Solostar2%Insulin Aspart1%Part D<11 patientsGLP-1 receptor agonist16.9%Trulicity38%Ozempic31%Mounjaro28%Victoza 3-Pak3%Part D<11 patients+ 10 more classes in this area
Hormonal (systemic)
22.7%l-Thyroxine17.8%Levothyroxine Sodium82%Synthroid18%Part D≥168 patientsThyroid Hormone Synthesis Inhibitor3.8%Methimazole100%Part D≥43 patients+ 2 more classes in this area
Cardiovascular
14.2%Statin5.5%Atorvastatin Calcium71%Pravastatin Sodium12%Simvastatin10%Rosuvastatin Calcium6%Part D<11 patientsAngiotensin receptor blocker (ARB)2.4%Losartan Potassium71%Losartan-Hydrochlorothiazide29%Part D<11 patients+ 8 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SUN-LB86 Case Report: Killian-Jamieson Diverticulum Presenting as a Thyroid Nodule
Journal of the Endocrine Society
2020 - Overcoming missed opportunities in diabetes management to improve outcomes for hospitalized patients with diabetes
Diabetes Research and Clinical Practice
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas File, MD
Summa Health System
Marc Penn, MD
Summa Health System
Drazen Petrinec, MD
Summa Health System
Sameer Mahesh, MD
Summa Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”